Categories: Research

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Major funding for The Kidney Project from NIBIB Quantum Program

The research journey toward building a fully functioning, surgically implantable artificial kidney as an alternative to kidney transplant and dialysis just took another step forward with the announcement of a $6 million grant to The Kidney Project, headquartered at the UCSF School of Pharmacy.

Burchard’s research highlighted in Newsweek

Esteban G. Burchard, MD, MPH, has been featured in Newsweek for his work studying genetic variation in asthma among minority populations. The article, titled “The Racial Discrimination Embedded in Modern Medicine,” was published online on October 20.

Fischbach joins project to generate drugs from bacterial genomes

Bacteria generate small molecules to fend off their fellow microbes. They also produce molecules that affect the response of host organisms—including humans—to their presence. Such molecules have been a major source of antibiotics, immunosuppressants, anti-cancer agents, and other drugs.

Pages